Published • loading... • Updated
Immune Checkpoint Inhibitor Combos Ranked for Liver Cancer in Major
Summary by BIOENGINEER.ORG
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Scienmag: Latest Science and Health NewsReposted by 
BIOENGINEER.ORG
BIOENGINEER.ORGImmune Checkpoint Inhibitor Combos Ranked for Liver Cancer in Major
A network meta-analysis of eight randomized trials finds that immune checkpoint inhibitors combined with anti-VEGF therapy outperform other immunotherapy combinations for hepatocellular carcinoma, except in patients with hepatitis C or non-viral liver disease.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
